EUVIMEDEUVIMED entdecken
Open Access

N 6-methyladenosine–dependent ARv7 translation couples lactate metabolism with enzalutamide resistance in prostate cancer

Meng Zhang iD, Bo Cheng iD, Man Jia, Xiang Li iD, Yingying Huang, Boyang Li, Xulin Wang, Jiawei Shao, Qinyue Deng, Wenjun Yu, Mingyu Li, Zhao Yang und 4 weitere

Science Advances · 06.11.2026 · 12 (45)

DOI: 10.1126/sciadv.aeg8317 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 06.11.2026. Verfasst von Meng Zhang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Anhui Province Key Laboratory of Genitourinary Diseases, The First Affiliated Hospital of Anhui Medical University, Anhui Medi…. Hauptthemen laut MEDLINE: Adenosine, Benzamides, Nitriles, Drug Resistance, Neoplasm. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Sichuan Science and Technology Program, Anhui Province Higher Education Science Research Project Outstanding Youth Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enzalutamide (Enz)–resistant prostate cancer (PCa) is a lethal disease that affects a broad population of elderly men. Experimental and clinical evidence has demonstrated that androgen receptor variant 7 (ARv7) plays a critical role in Enz-resistant (EnzR) PCa by functioning as a constitutively active transcription factor driving disease progression. However, the predictive value of the ARv7 transcript has not been fully recognized due to its low frequency in castration-resistant PCa. In this study, we identified ARv7 mRNA as an N 6-methyladenosine (m 6 A)–modified transcript. Enz treatment increases METTL3-dependent m 6 A methylation of ARv7 mRNA at the A1177 site, which is subsequently recognized by the reader protein YTHDC2, leading to enhanced translation efficiency of ARv7. Furthermore, EnzR PCa exhibited elevated lactate metabolism, which regulated AR transcription through promoter-mediated epigenetic modifications at H3K9 and H3K14. Reactivated AR exhibited enhanced phase separation to transcriptionally up-regulate YTHDC2 expression. In vivo experiments demonstrated that targeting the METTL3-YTHDC2-ARv7 axis represents a promising therapeutic strategy to suppress EnzR PCa progression. Moreover, the METTL3 inhibitor STM2457 synergized with Enz to inhibit tumor growth without observable toxicity. Collectively, our findings suggest that the clinical utility of ARv7 may need to be reconsidered in light of its m 6 A-dependent translational regulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenosineBenzamidesNitrilesDrug Resistance, NeoplasmPhenylthiohydantoinReceptors, AndrogenProstatic NeoplasmsProtein BiosynthesisMaleHumansAnimalsGene Expression Regulation, NeoplasticRNA MethylationCell Line, TumorMethyltransferasesEpitranscriptomeMice

Substanzen

AdenosineBenzamidesNitrilesN-methyladenosineenzalutamidePhenylthiohydantoinReceptors, AndrogenMethyltransferasesMETTL3 protein, human

Autor:innen und Institutionen

  • Department of Urology, Anhui Province Key Laboratory of Genitourinary Diseases, The First Affiliated Hospital of Anhui Medical University, Anhui Medical University, Hefei, Anhui 230022, China.
  • Department of Urology, The Affiliated Hospital of Southwest Medical University, Southwest Medical University, Luzhou, Sichuan 646000, China.
  • Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Southwest Medical University, Luzhou, Sichuan 646000, China.
  • Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China.
  • Tianjin Medical University, Tianjin 300000, China.
  • Department of Biochemistry and Molecular Biology, Institute of Basic Medicine, North Sichuan Medical College, Nanchong, Sichuan 637000, China.

ORCID-Profile: Meng Zhang, Bo Cheng, Xiang Li, Chaozhao Liang, Tian Li, Rongyang Dai, Ronghao Wang

Förderung

  • National Natural Science Foundation of China
  • Sichuan Science and Technology Program
  • Anhui Province Higher Education Science Research Project Outstanding Youth Research Project
  • Strategic Cooperation Project of Southwest Medical University

Zitieren

APA

Zhang, M., Cheng, B., Jia, M., Li, X., Huang, Y., Li, B., Wang, X., Shao, J., Deng, Q., Yu, W., Li, M., Yang, Z., Liang, C., Li, T., Dai, R., & Wang, R. (2026). N 6-methyladenosine–dependent ARv7 translation couples lactate metabolism with enzalutamide resistance in prostate cancer. Science Advances, 12(45). https://doi.org/10.1126/sciadv.aeg8317

Vancouver

Zhang M, Cheng B, Jia M, Li X, Huang Y, Li B, et al. N 6-methyladenosine–dependent ARv7 translation couples lactate metabolism with enzalutamide resistance in prostate cancer. Science Advances. 2026;12(45). doi:10.1126/sciadv.aeg8317

BibTeX
@article{Zhang2026,
  author = {Zhang, Meng and Cheng, Bo and Jia, Man and Li, Xiang and Huang, Yingying and Li, Boyang and Wang, Xulin and Shao, Jiawei and Deng, Qinyue and Yu, Wenjun and Li, Mingyu and Yang, Zhao and Liang, Chaozhao and Li, Tian and Dai, Rongyang and Wang, Ronghao},
  title = {N 6-methyladenosine–dependent ARv7 translation couples lactate metabolism with enzalutamide resistance in prostate cancer},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {45},
  doi = {10.1126/sciadv.aeg8317}
}
Kostenlos starten →